In-Licensing Opportunity Assessment in a Subsegment of Anticoagulant Agents for the EU-5 Market

Publications September 19, 2023

Opportunities and Challenges in the Therapeutic and CDMO Markets

Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.

CDMO Pharma

News August 31, 2023

Alira Health Named One of the World’s Best Management Consulting Firms by Forbes

Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.

Life Sciences MedTech Pharma

Publications August 1, 2023

The EU Pharmaceutical Package: Impact on Orphan Medicinal Products

This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).

EU Pharma Regulatory

Publications July 25, 2023

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.

Market Access Pharma

Blog July 24, 2023

What EU Companies Need to Know about the U.S. Inflation Reduction Act

We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.

Biotech Drug Development Pharma

Publications July 11, 2023

Mid-size Pharma Accelerates Early Clinical Trial Engagement of Patients with A Rare Neurological Disease

A mid-size pharma company sought an experienced advisor who could help them engage patients for an open-label extension clinical study in a rare neurological disease.

Clinical Trials Patient Engagement Pharma Rare Disease

Publications July 10, 2023

The EU Pharmaceutical Package: Regulatory Protection Changes

Our regulatory experts present a more detailed analysis of the proposed changes introduced to Regulatory Data Protection (RDP).

EU Pharma Regulatory